Crosstalk of inflammatory cytokines within the breast tumor microenvironment
O Habanjar, R Bingula, C Decombat… - International journal of …, 2023 - mdpi.com
Several immune and immunocompetent cells, including dendritic cells, macrophages,
adipocytes, natural killer cells, T cells, and B cells, are significantly correlated with the …
adipocytes, natural killer cells, T cells, and B cells, are significantly correlated with the …
Akt signalling in health and disease
I Hers, EE Vincent, JM Tavaré - Cellular signalling, 2011 - Elsevier
Akt (also known as protein kinase B or PKB) comprises three closely related isoforms Akt1,
Akt2 and Akt3 (or PKBα/β/γ respectively). We have a very good understanding of the …
Akt2 and Akt3 (or PKBα/β/γ respectively). We have a very good understanding of the …
Perturbations of the AKT signaling pathway in human cancer
DA Altomare, JR Testa - Oncogene, 2005 - nature.com
Abstract AKT/PKB (protein kinase B) kinases mediate signaling pathways downstream of
activated tyrosine kinases and phosphatidylinositol 3-kinase. AKT kinases regulate diverse …
activated tyrosine kinases and phosphatidylinositol 3-kinase. AKT kinases regulate diverse …
FOXO transcription factors at the interface between longevity and tumor suppression
A wide range of human diseases, including cancer, has a striking age-dependent onset.
However, the molecular mechanisms that connect aging and cancer are just beginning to be …
However, the molecular mechanisms that connect aging and cancer are just beginning to be …
Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue, A Bellacosa - Oncogene, 2005 - nature.com
Epithelial–mesenchymal transition (EMT) is an important process during development by
which epithelial cells acquire mesenchymal, fibroblast-like properties and show reduced …
which epithelial cells acquire mesenchymal, fibroblast-like properties and show reduced …
Current development of mTOR inhibitors as anticancer agents
S Faivre, G Kroemer, E Raymond - Nature reviews Drug discovery, 2006 - nature.com
Mammalian target of rapamycin (mTOR) is a kinase that functions as a master switch
between catabolic and anabolic metabolism and as such is a target for the design of …
between catabolic and anabolic metabolism and as such is a target for the design of …
Mechanisms of disease: oncogene addiction—a rationale for molecular targeting in cancer therapy
IB Weinstein, AK Joe - Nature clinical practice Oncology, 2006 - nature.com
There has been considerable progress in the systemic treatment of cancer because of the
rapid development and clinical application of molecular targeted agents. Although patients …
rapid development and clinical application of molecular targeted agents. Although patients …
Taxanes, microtubules and chemoresistant breast cancer
BT McGrogan, B Gilmartin, DN Carney… - Biochimica et Biophysica …, 2008 - Elsevier
The taxanes, paclitaxel and docetaxel are microtubule-stabilizing agents that function
primarily by interfering with spindle microtubule dynamics causing cell cycle arrest and …
primarily by interfering with spindle microtubule dynamics causing cell cycle arrest and …